Skip to main content
. 2013 Jul 20;16(7):345–352. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2013.07.03

5.

吉非替尼组和厄洛替尼组不良反应

Adverse effects in gefitinib-treated and erlotinib-treated patients

Adverse effect Gefitinib group (n=30) Erlotinib group (n=31) P
Rash 11 (36.67%) 20 (64.51%) 0.030, 1
Diarrhea 7 (23.33%) 7 (22.58%) 0.944, 3
Asthenia 5 (16.67%) 4 (12.90%) 0.679, 2
Anorexia 5 (16.67%) 5 (16.13%) 0.955, 3
Dry skin 4 (13.33%) 4 (12.90%) 0.969, 0
Nausea/vomiting 3 (10.00%) 4 (12.90%) 0.722, 4
Hand-foot syndrome 3 (10.00%) 3 (9.67%) 0.966, 0
Stomatitis 3 (10.00%) 2 (6.45%) 0.785, 2